All News Archives | Page 13 of 19

Relievant Announces Publication of Positive Results from Multi-Center Study of the Intracept® Procedure in Real-world Setting for Patients with Chronic Low Back Pain

MINNEAPOLIS – August 27, 2019 – Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the publication of significant and clinically-meaningful outcomes from a prospective, open-label, single-arm, multi-center study in the European Spine Journal. This study follows previous publication of [...]

Endeavour Vision2023-04-06T10:28:15+01:00August 27th, 2019|All News, Company News|

V-Wave’s Interatrial Shunt Receives FDA Breakthrough Device Designation for Heart Failure

V-Wave’s Interatrial Shunt Receives FDA Breakthrough Device Designation for Heart Failure CAESAREA, Israel, Aug. 15, 2019 — V-Wave Ltd., a privately held medical device company developing novel implantable interatrial shunt devices, today announced that the U.S. Food and Drug Administration (FDA) has just granted the company a Breakthrough [...]

Endeavour Vision2023-04-03T11:08:50+01:00August 19th, 2019|All News, Company News|

Molecular Partners’ strategic partner Allergan announces that EMA has validated the marketing authorisation application for abicipar

Zurich-Schlieren, Switzerland, August 06, 2019. Molecular Partners AG (SIX: MOLN), a clinical-stage biotech company that is developing a new class of drugs known as DARPin® therapies*, today announced that the European Medicines Agency (EMA) has validated the marketing authorisation application (MAA) of its strategic partner Allergan for abicipar, a [...]

fp_rick2023-04-05T10:32:29+01:00August 7th, 2019|All News, Company News, Previous Sectors|

Interview with Rob Barmann, Senior Investment Director at Endeavour Vision

Previously Vice President, Corporate Business Development at Boston Scientific. Rob, you joined Endeavour Vision after 15 years working at Boston Scientific, can you summarise your role there? My job was to assess and execute business development transactions including acquisitions, joint ventures, distribution deals and minority investments etc. on behalf [...]

fp_rick2023-05-04T16:06:47+01:00July 24th, 2019|All News, Blog|

Interview with Kevin Hykes, President & CEO at Relievant

Can you tell us a bit about Relievant Medsystems and the Intracept® Procedure? Relievant is a venture-backed medical device company founded in 2006, based in Minneapolis and Sunnydale, California with around 45 employees. Our focus is currently shifting from research and development and clinical trial execution to commercial with [...]

fp_rick2023-05-08T09:06:53+01:00June 12th, 2019|All News, Blog|

CeQur appoints Bradley Paddock Chief Executive Officer

Medical Device Veteran Has 23-Year Record of Successful Commercial and Organizational Leadership MARLBOROUGH, Mass., June 5, 2019 — CeQur® announced that the company has appointed Bradley Paddock as chief executive officer, effective today. Paddock brings a track record of commercial medtech successes, notably leading sales up to $600 million [...]

fp_rick2023-04-12T12:40:58+01:00June 6th, 2019|All News, Blog, Company News|

Interview with Chris Owens, CEO & President at Gynesonics, Inc

What is Gynesonics about? How are you changing the standard of care in uterine fibroids? Gynesonics is focused on advancing women’s health by developing uterus-preserving, incision free, transcervical technology. Currently, we are focused on the treatment of symptomatic uterine fibroids, a condition that affects up to 50% of women [...]

fp_rick2023-04-12T13:51:29+01:00May 24th, 2019|All News, Blog|

Boston Scientific Announces Agreement to Acquire Vertiflex, Inc.

Boston Scientific Announces Agreement to Acquire Vertiflex, Inc. Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies. Vertiflex has raised approximately $160 million in funding from investors including Endeavour Vision, NEA and H.I.G. BioVentures. MARLBOROUGH, Mass., May 9, 2019 / — Boston Scientific (NYSE: [...]

fp_rick2023-04-03T13:10:30+01:00May 9th, 2019|All News, Company News|

Nuvaira receives French innovation funding for Nuvaira Airflow-3 pivotal trial

Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies. Novel program provides reimbursement for TLD therapy in France MINNEAPOLIS, April 28, 2018 – Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, has received acceptance from the Haute Autorité de Santé (HAS, the [...]

fp_rick2023-07-24T16:48:36+01:00May 6th, 2019|All News, Company News|

Relievant announces publication of SMART trial 24-month results

Intracept® Procedure Demonstrates Durable Results at 24 Months. MINNEAPOLIS – April 24, 2019 – Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today announced the publication of 24-month results from the SMART trial in the International Journal of Spine Surgery. A [...]

fp_rick2023-04-03T16:04:54+01:00April 28th, 2019|All News, Company News|